Xin Hong
Hebei Medical University(CN)Second Hospital of Hebei Medical University(CN)
Publications by Year
Research Areas
RNA modifications and cancer, Ferroptosis and cancer prognosis, Cancer, Lipids, and Metabolism, Lymphoma Diagnosis and Treatment, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial.(2011)1,622 cited
- → The genetic basis of early T-cell precursor acute lymphoblastic leukaemia(2012)1,622 cited
- → Novel mutations target distinct subgroups of medulloblastoma(2012)851 cited
- → Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity(2007)582 cited
- → The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors(2009)528 cited
- → Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells(2009)492 cited